Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Comparing Beta-Blocking Effects of Bisoprolol, Carvedilol and Nebivolol

View through CrossRef
<i>Objective:</i> Bisoprolol, carvedilol and nebivolol have been shown to be effective in the treatment of heart failure. However, the beta-blocking effects of these drugs have never been compared directly. <i>Methods:</i> Therefore, we performed a randomized, double-blind, placebo-controlled, cross-over trial in 16 healthy males. Subjects received 10 mg bisoprolol, 50 mg carvedilol, 10 mg nebivolol and placebo on the first morning followed by 5 mg bisoprolol once daily, 25 mg carvedilol twice daily, 5 mg nebivolol once daily and placebo for 1 week. Heart rate and blood pressure were measured at rest and exercise 3 and 24 h following intake of the first dose, and immediately before and 3 hours following intake of the last dose of each drug. In addition, effects of the drugs on nocturnal melatonin release were determined, and quality of life (QOL) was evaluated. <i>Results:</i> Heart rate at exercise was decreased at 3 h following intake of the first single dose of each drug by bisoprolol (–24%), carvedilol (–17%) and nebivolol (–15%), and at 24 h following intake of the respective last dose of each drug following 1 week of chronic administration by bisoprolol (–14%), carvedilol (12 h; –15%) and nebivolol (–13%) (p < 0.05 in all cases). Thus, trough-to-peak-ratios at long-term were as follows: Bisoprolol, 58%; carvedilol (12 h), 85%; nebivolol, 91%. Nocturnal melatonin release was decreased by bisoprolol (–44%, p < 0.05) whereas nebivolol and carvedilol had no effect. QOL with carvedilol was slightly but significantly lower than with the other drugs, whereas bisoprolol and nebivolol did not alter QOL. <i>Conclusions:</i> These data show that peak beta-blocking effects of bisoprolol appear stronger than those of nebivolol and carvedilol. On the other hand, nebivolol exerts the highest trough-to-peak-ratio. However, beta-blocking effects of all the three drugs are similar at trough. Only bisoprolol but neither nebivolol nor carvedilol decreased nocturnal melatonin release, a feature which might cause sleep disturbances. Finally, only carvedilol slightly decreased QOL, whereas nebivolol and bisoprolol did not affect QOL. We conclude that different beta-blockers may exert clinically relevant different effects.
Title: Comparing Beta-Blocking Effects of Bisoprolol, Carvedilol and Nebivolol
Description:
<i>Objective:</i> Bisoprolol, carvedilol and nebivolol have been shown to be effective in the treatment of heart failure.
However, the beta-blocking effects of these drugs have never been compared directly.
<i>Methods:</i> Therefore, we performed a randomized, double-blind, placebo-controlled, cross-over trial in 16 healthy males.
Subjects received 10 mg bisoprolol, 50 mg carvedilol, 10 mg nebivolol and placebo on the first morning followed by 5 mg bisoprolol once daily, 25 mg carvedilol twice daily, 5 mg nebivolol once daily and placebo for 1 week.
Heart rate and blood pressure were measured at rest and exercise 3 and 24 h following intake of the first dose, and immediately before and 3 hours following intake of the last dose of each drug.
In addition, effects of the drugs on nocturnal melatonin release were determined, and quality of life (QOL) was evaluated.
<i>Results:</i> Heart rate at exercise was decreased at 3 h following intake of the first single dose of each drug by bisoprolol (–24%), carvedilol (–17%) and nebivolol (–15%), and at 24 h following intake of the respective last dose of each drug following 1 week of chronic administration by bisoprolol (–14%), carvedilol (12 h; –15%) and nebivolol (–13%) (p < 0.
05 in all cases).
Thus, trough-to-peak-ratios at long-term were as follows: Bisoprolol, 58%; carvedilol (12 h), 85%; nebivolol, 91%.
Nocturnal melatonin release was decreased by bisoprolol (–44%, p < 0.
05) whereas nebivolol and carvedilol had no effect.
QOL with carvedilol was slightly but significantly lower than with the other drugs, whereas bisoprolol and nebivolol did not alter QOL.
<i>Conclusions:</i> These data show that peak beta-blocking effects of bisoprolol appear stronger than those of nebivolol and carvedilol.
On the other hand, nebivolol exerts the highest trough-to-peak-ratio.
However, beta-blocking effects of all the three drugs are similar at trough.
Only bisoprolol but neither nebivolol nor carvedilol decreased nocturnal melatonin release, a feature which might cause sleep disturbances.
Finally, only carvedilol slightly decreased QOL, whereas nebivolol and bisoprolol did not affect QOL.
We conclude that different beta-blockers may exert clinically relevant different effects.

Related Results

Differing Beta-Blocking Effects of Carvedilol and Metoprolol
Differing Beta-Blocking Effects of Carvedilol and Metoprolol
Abstract Background Metoprolol is a beta1-selective beta-adrenergic antagonist while carvedilol is a non-selective beta-b...
Both Carvedilol and Nebivolol May Improve Platelet Function and Prothrombotic State in Patients With Nonischemic Heart Failure
Both Carvedilol and Nebivolol May Improve Platelet Function and Prothrombotic State in Patients With Nonischemic Heart Failure
It is unclear whether carvedilol and nebivolol will produce different effects on platelet function and prothrombotic state in heart failure (HF). Thus, we compared their effects on...
Carvedilol ameliorates experimental atherosclerosis by inhibiting the NLRP3 inflammasome
Carvedilol ameliorates experimental atherosclerosis by inhibiting the NLRP3 inflammasome
Abstract Objective: To investigate the protective effect of carvedilol against atherosclerosis by inhibiting the NLRP3 inflammasome. Methods:In vitro experiments, human umb...
The dose dependency of the alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol in man.
The dose dependency of the alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol in man.
1. The alpha‐ and beta‐adrenoceptor antagonist activity of carvedilol, a beta‐adrenoceptor antagonist with vasodilating properties, and labetalol were investigated in 10 healthy ma...
DESIGN AND EVALUATION OF LIQUISOLID COMPACTS OF NEBIVOLOL HYDROCHLORIDE
DESIGN AND EVALUATION OF LIQUISOLID COMPACTS OF NEBIVOLOL HYDROCHLORIDE
Objective: The aim of this study was to investigate the potential of a liquisolid system to improve the dissolution rate and the bioavailability of nebivolol hydrochloride. Methods...
Development and Evaluation of Self Micro Emulsifying Drug Delivery System (SMEDDS) for Nebivolol Hydrochloride
Development and Evaluation of Self Micro Emulsifying Drug Delivery System (SMEDDS) for Nebivolol Hydrochloride
The  present  investigation  aimed  to  prepare  a  self  micro  emulsifying  drug  delivery  system  (SMEDDS)  for  the dissolution enhancement of nebivolol hydrochloride.  The ma...
Carvedilol Versus Propranolol in the Prevention of Variceal Rebleeding in Hepatic Schistosomiasis: Efficacy and Safety
Carvedilol Versus Propranolol in the Prevention of Variceal Rebleeding in Hepatic Schistosomiasis: Efficacy and Safety
Abstract Background: The betablockers combined with endoscopic variceal band ligation (EVL) is the most effective prevention of variceal rebleeding. The aim of this study i...

Back to Top